MEDvs its industry peers
A metric-by-metric comparison of MED against SIC 2090 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MEDThis | $143M#2 | — | 0.8x#1 | 0.4x#2 | -36.0%#3 | -1050.0%#3 | -3.7%#3 | -10.5%#3 | — | 4#1 | — | 0.1%#3 |
| JVA | $27M#3 | 5.8x#1 | 0.9x#2 | 0.3x#1 | 22.6%#1 | -36.7%#2 | 2.2%#2 | 4.5%#2 | — | — | 24.9%#1 | 1.5%#2 |
| MKC.V | $13.7B#1 | 9.2x#2 | 2.0x#3 | 2.0x#3 | 1.7%#2 | 0.1%#1 | 15.7%#1 | 11.3%#1 | 7.7%#1 | — | -17.1%#2 | 3.5%#1 |
Peer set: US filers sharing this company's SEC industry classification (SIC 2090). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-06.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice